Literature DB >> 23618812

Genetic background and tumour susceptibility in mouse models.

J Puccini, L Dorstyn, S Kumar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23618812      PMCID： PMC3679461          DOI： 10.1038/cdd.2013.35

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN： 1350-9047            Impact factor:   15.828


× No keyword cloud information.
  9 in total

1.  Differences in animal housing facilities and diet may affect study outcomes-a plea for inclusion of such information in publications.

Authors:  Ramune Reliene; Robert H Schiestl
Journal:  DNA Repair (Amst)       Date:  2006-04-03

2.  Genetic and environmental effects on complex traits in mice.

Authors:  William Valdar; Leah C Solberg; Dominique Gauguier; William O Cookson; J Nicholas P Rawlins; Richard Mott; Jonathan Flint
Journal:  Genetics       Date:  2006-08-03       Impact factor: 4.562

3.  Targeted expression of MYCN causes neuroblastoma in transgenic mice.

Authors:  W A Weiss; K Aldape; G Mohapatra; B G Feuerstein; J M Bishop
Journal:  EMBO J       Date:  1997-06-02       Impact factor: 11.598

4.  RAG-mediated V(D)J recombination is not essential for tumorigenesis in Atm-deficient mice.

Authors:  Lisa K Petiniot; Zoë Weaver; Melanie Vacchio; Rhuna Shen; Danny Wangsa; Carrolee Barlow; Michael Eckhaus; Seth M Steinberg; Anthony Wynshaw-Boris; Thomas Ried; Richard J Hodes
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

5.  Effects of genetic background on tumorigenesis in p53-deficient mice.

Authors:  L A Donehower; M Harvey; H Vogel; M J McArthur; C A Montgomery; S H Park; T Thompson; R J Ford; A Bradley
Journal:  Mol Carcinog       Date:  1995-09       Impact factor: 4.784

6.  The loss of the BH3-only Bcl-2 family member Bid delays T-cell leukemogenesis in Atm-/- mice.

Authors:  S Biswas; Q Shi; A Wernick; A Aiello; S S Zinkel
Journal:  Cell Death Differ       Date:  2013-03-08       Impact factor: 15.828

Review 7.  Influence of genetic background on genetically engineered mouse phenotypes.

Authors:  Thomas Doetschman
Journal:  Methods Mol Biol       Date:  2009

Review 8.  Genetic background and the dilemma of translating mouse studies to humans.

Authors:  Juan Rivera; Lino Tessarollo
Journal:  Immunity       Date:  2008-01       Impact factor: 31.745

9.  HCV tumor promoting effect is dependent on host genetic background.

Authors:  Naama Klopstock; Mark Katzenellenbogen; Orit Pappo; Miriam Sklair-Levy; Devorah Olam; Lina Mizrahi; Tamara Potikha; Eithan Galun; Daniel Goldenberg
Journal:  PLoS One       Date:  2009-04-02       Impact factor: 3.240
  9 in total
  6 in total

1.  An unexpected role for caspase-2 in neuroblastoma.

Authors:  L Dorstyn; J Puccini; A Nikolic; S Shalini; C H Wilson; M D Norris; M Haber; S Kumar
Journal:  Cell Death Dis       Date:  2014-08-21       Impact factor: 8.469

2.  Validation of simple sequence length polymorphism regions of commonly used mouse strains for marker assisted speed congenics screening.

Authors:  Channabasavaiah B Gurumurthy; Poonam S Joshi; Scott G Kurz; Masato Ohtsuka; Rolen M Quadros; Donald W Harms; K C Kent Lloyd
Journal:  Int J Genomics       Date:  2015-02-28       Impact factor: 2.326

3.  Perforin-dependent direct cytotoxicity in natural killer cells induces considerable knockdown of spontaneous lung metastases and computer modelling-proven tumor cell dormancy in a HT29 human colon cancer xenograft mouse model.

Authors:  Tobias Brodbeck; Nina Nehmann; Anja Bethge; Gero Wedemann; Udo Schumacher
Journal:  Mol Cancer       Date:  2014-11-05       Impact factor: 27.401

4.  Absence of ERK5/MAPK7 delays tumorigenesis in Atm-/- mice.

Authors:  Alba Granados-Jaén; Maria Angulo-Ibáñez; Xavier Rovira-Clavé; Celina Paola Vasquez Gamez; Francesc X Soriano; Manuel Reina; Enric Espel
Journal:  Oncotarget       Date:  2016-11-15

5.  GLIPR1 expression is reduced in multiple myeloma but is not a tumour suppressor in mice.

Authors:  Natasha Friend; Jacqueline E Noll; Khatora S Opperman; Kimberley C Clark; Krzysztof M Mrozik; Kate Vandyke; Duncan R Hewett; Andrew C W Zannettino
Journal:  PLoS One       Date:  2020-01-29       Impact factor: 3.240

6.  RASSF10 is frequently epigenetically inactivated in kidney cancer and its knockout promotes neoplasia in cancer prone mice.

Authors:  Antje M Richter; Michelle L Woods; Miriam M Küster; Sara K Walesch; Thomas Braun; Thomas Boettger; Reinhard H Dammann
Journal:  Oncogene       Date:  2020-02-11       Impact factor: 9.867
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.